In preclinical studies, the use of AMG510 in immune-competent mice allowed T cells, especially CD8+ T cells, to infiltrate a large number of tumours, resulting in a pro-inflammatory tumour microenvironment that produced durable responses alone or in combination with ICI (22). Here, CD8A is linked to neoplasm.